Aspects of early diagnosis, treatment, disease activity, pathogenesis, prognosis, biomarkers, comorbidity, compliance, adherence and quality of life in:
- Rheumatoid arthritis
- Psoriatic arthritis
- Spondyloarthropathy
- Arthritis urica
- Sarcoidosis
- ANCA-associated vasculitis
- Systemic lupus erythematosus
- Cerebral vasculitis
- Systemic sclerosis
- Idiopathic inflammatory myopathies
- Tendinopathy
In clinically well characterised cohorts/trials: Inception and trans-sectional cohorts Investigator initiated trials Randomized and open treatment strategy studies with synthetic and biological DMARD (Disease Modifying Anti Rheumatic Drugs) as well as training strategies.
